Associate Director, Investor Relations

Position Summary:

Apellis is looking to hire a driven and knowledgeable Associate Director, Investor Relations to join the Finance team. Reporting into the Head of Investor Relations, this individual will contribute significantly to the development and execution of an integrated communications strategy that aligns with and promotes Apellis’ value proposition, milestones and achievements and will serve as a point of contact for the investment community.

Responsibilities:

• Help to plan and execute a comprehensive, strategic investor relations program to increase Apellis’ visibility with the investment community
• Collaborate on quarterly earnings processes – preparation of materials including earnings conference call scripts, press releases, Q&A documents, and other associated materials for sell-side and buy-side post-earnings calls

• Maintain analyst consensus spreadsheet, collaborating closely with finance to develop a comprehensive understanding of both internal and external expectations
• Prepare materials for Board of Directors and executive committee on IR activities, share ownership, and valuation as needed

• Assist with the ongoing refinement of key messaging and market positioning based on company performance, market perception, expectations, peer performance and relative valuation

• Provide counsel to senior leadership on how to effectively engage with the investment community
• Support additional investor-focused conference calls, meetings, analyst days, and non-deal roadshows

• Ensure compliance with regulatory requirements and industry standards in all communications activities
• Serve as a point of contact for the investment community

Qualifications:

• Bachelor's degree in business, finance or accounting related; advanced degree preferred.

• Over 10 years of relevant experience, ideally in investor relations, equity research, or capital markets within the biotechnology or life sciences industry.
• Ability to travel occasionally.

Skills, Knowledge, and Abilities:

• Financial modeling expertise and comprehension of valuation methods used by analysts and investors
• Understanding of regulatory compliance and reporting requirements for publicly traded companies; familiarity with scientific or healthcare regulations and market
• Working knowledge and understanding of the capital markets, as well as a thorough understanding of key metrics for companies in the industry
• Communication skills and presence: ability to express oneself clearly and concisely with excellent interpersonal skills, written and verbal communications
• Strong attention to detail, both in messaging and in written documents
• Ability to work in a fast-paced environment and to handle multiple tasks

Benefits and Perks:

Base salary for this role will consider multiple factors, including but not limited to, candidate qualifications, relevant expertise, specialized skills, and industry experience in complement-targeted therapies.

The targeted base salary range for this position is $178,000.00 - $267,000.00 per year. This range represents the base salary only and reflects Apellis' commitment to competitive compensation within the biopharmaceutical industry. The final salary offered may vary based on individual qualifications, business needs, and current market conditions. per year. This range represents the base salary only and reflects Apellis' commitment to competitive compensation within the biopharmaceutical industry. The final salary offered may vary based on individual qualifications, business needs, and current market conditions.

Apellis offers a comprehensive benefits package, including a 401(k) plan with company match, inclusive family building benefits, flexible time off, summer and winter shutdowns, paid family leave, disability and life insurance, and more! Visit https://apellis.com/careers/benefits/ to learn more.
Company Background:

Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two approved medicines targeting C3. These include the first and only therapy for geographic atrophy, a leading cause of blindness around the world. With nearly a dozen clinical and pre-clinical programs underway, we believe we have only begun to unlock the potential of targeting C3 across many serious diseases.

For more information, please visit http://apellis.com or follow us on Twitter and LinkedIn

EEO Statement:

Apellis is an equal opportunity employer and complies with all applicable federal, state and local fair employment practices laws. Apellis strictly prohibits and does not tolerate discrimination against employees, applicants or any other covered persons because of race, color, religion, creed, national origin or ancestry, ethnicity, sex (including pregnancy), gender (including gender nonconformity and status as a transgender or transsexual individual), age, physical or mental disability, citizenship, past, current or prospective service in the uniformed services, genetic information, marital status, AIDS/HIV status, smoker/nonsmoker, and occupational pneumoconiosis or any other characteristic protected under applicable federal, state or local law.

For San Francisco postings: Pursuant to the San Francisco Fair Chance Ordinance, we will consider for employment qualified applicants with arrest and conviction records.  

Other Duties:

Please note this job description is not designed to cover or contain a comprehensive listing of activities, duties or responsibilities that are required of the employee for this job. Duties, responsibilities and activities may change at any time with or without notice.